Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2022 | Co- occurring HER2 and PD-L1 expression in patients with HER2-positive trastuzumab-refractory gastric cancer (GC)/gastroesophageal junction adenocarcinoma (GEJA): Biomarker analysis from the trastuzumab deruxtecan (T-DXd) DESTINY-Gastric03 trial | ANNALS OF ONCOLOGY |